| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 5,277,000 | 5,164,000 | 5,199,000 | 7,934,000 | | Cost of Revenue | 3,156,000 | 3,021,000 | 3,219,000 | 4,812,000 | | | Gross Profit | 2,121,000 | 2,143,000 | 1,980,000 | 3,122,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,238,000 | 1,861,000 | 1,956,000 | 2,256,000 | | Non Recurring | (172,000) | 34,000 | 138,000 | 5,601,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 55,000 | 248,000 | (114,000) | (4,735,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,000 | 2,000 | 2,000 | 5,000 | | Earnings Before Interest And Taxes | 57,000 | 250,000 | (112,000) | (4,730,000) | | Interest Expense | 139,000 | 141,000 | 143,000 | 148,000 | | Income Before Tax | (82,000) | 109,000 | (255,000) | (4,878,000) | | Income Tax Expense | (47,000) | 102,000 | (167,000) | (105,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (35,000) | 7,000 | (88,000) | (4,773,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (35,000) | 7,000 | (88,000) | (4,773,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($35,000) | $7,000 | ($88,000) | ($4,773,000) |
|
1.27% Nasdaq 0.00%
Income Statement
